Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial-Reference-Cited by-同舟云学术

Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial

Author:

Lorenzatti Alberto J.¹^ORCID,Eliaschewitz Freddy G.²,Chen Yundai³,Lu Juming⁴,Baass Alexis⁵,Monsalvo Maria Laura⁶,Wang Nan⁶,Hamer Andrew W.⁶,Ge Junbo⁷

Affiliation:

1. Clinical Research and CardiologyInstituto Medico DAMIC / Fundación Rusculleda Córdoba Argentina

2. CPCLIN – Centro de Pesquisas Clínicas Rua Goias São Paulo Brazil

3. Department of CardiologyChinese People's Liberation Army General Hospital Beijing China

4. Department of EndocrinologyChinese People's Liberation Army General Hospital Beijing China

5. Department of MedicineRoyal Victoria Hospital Montreal Québec Canada

6. Clinical DevelopmentAmgen Inc. Thousand Oaks California USA

7. Department of Cardiology, Shanghai Institute of Cardiovascular DiseasesZhongshan Hospital, Fudan University Shanghai China

Funder

Amgen Inc.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference44 articles.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献